Electromed authorizes $5.0 million share repurchase program

Electromed, Inc.

Board authorized repurchase of up to $5.0M of common stock, effective September 11, 2024.
New authorization follows exhaustion of prior repurchase program in Q4 fiscal 2024.
Repurchases may occur on open market or in private transactions, at management's discretion.
CEO Jim Cunniff cited strong FY2024 results and belief stock is undervalued as rationale.
Authorization reinforces commitment to shareholder returns while continuing to invest in the business.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.